40 mg famotidine pill identifier

If you are a consumer or patient please visit this version. Famotidine is a histamine-2 H 2 receptor antagonist indicated 1 :.

The active ingredient in famotidine tablets USP is a histamine H 2 -receptor antagonist. Famotidine, USP is [1-Amino[[[2-[ diaminomethylene amino]thiazolyl]methyl]thio] propylidene] sulfamide and has the following structural formula:. Famotidine, USP is a white to pale yellow crystalline compound that is freely soluble in glacial acetic acid, slightly soluble in methanol, very slightly soluble in water, and practically insoluble in ethanol. Each tablet for oral administration contains either 20 mg or 40 mg of famotidine, USP and has the following inactive ingredients: colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized corn starch, sodium starch glycolate, talc, titanium dioxide, yellow iron oxide. Famotidine is a competitive inhibitor of histamine H 2 -receptors. The primary clinically important pharmacologic activity of famotidine is inhibition of gastric secretion.

40 mg famotidine pill identifier

.

Famotidine tablets are contraindicated in patients with a history of serious hypersensitivity reactions e. Hypersensitivity to any component of this product. Trials have not assessed the safety of famotidine in uncomplicated active GU for periods of more than 8 weeks.

.

Famotidine tablets is a histamine-2 H 2 receptor antagonist indicated 1 :. Adult and Pediatric Patients. Administration 2. History of serious hypersensitivity reactions e. The most common adverse reactions are: headache, dizziness, constipation, and diarrhea. Famotidine tablets are indicated in adult and pediatric patients 40 kg and greater for the treatment of:. Table 1 shows the recommended dosage of famotidine 20 mg and 40 mg tablets in adult and pediatric patients weighing 40 kg and greater with normal renal function. The use of famotidine 20 mg and 40 mg tablets is not recommended in pediatric patients weighing less than 40 kg because the lowest available strength 20 mg exceeds the recommended dose for these patients. Use another famotidine formulation for pediatric patients weighing less than 40 kg.

40 mg famotidine pill identifier

Famotidine is used to treat stomach ulcers gastric and duodenal , erosive esophagitis heartburn or acid indigestion , and gastroesophageal reflux disease GERD. GERD is a condition where the acid in the stomach washes back up into the esophagus. It is also used to treat certain conditions where there is too much acid in the stomach eg, Zollinger-Ellison syndrome, multiple endocrine neoplasia. Famotidine belongs to the group of medicines known as histamine H2-receptor antagonists or H2-blockers.

Home depot jiutepec

Prolonged QT interval, in patients with impaired renal function, has been reported very rarely. Famotidine tablets may be taken with or without food. When famotidine was given after breakfast, the basal daytime interdigestive pH at 3 and 8 hours after 20 or 40 mg of famotidine was raised to about 5. As shown in Table 6, patients treated with famotidine 20 mg twice daily had greater improvement in symptomatic GERD than patients treated with 40 mg at bedtime or placebo. Treatment of pathological hypersecretory conditions e. Drug Label Info. A total of patients were treated with famotidine, including treated with 40 mg twice daily, treated with 20 mg twice daily, treated with 40 mg once daily, and treated with 20 mg once daily. Also, caregivers were instructed to provide conservative treatment including thickened feedings. The clinical relevance of this interaction is unknown. Renal clearance, urinary excretion rate and amount of famotidine excreted unchanged in urine were decreased. North Wales, PA Rev. In adults for the: treatment of pathological hypersecretory conditions e. In contrast, pediatric patients 0 to 3 months of age had famotidine clearance values that were 2 to 4 fold less than those in older pediatric patients and adults. Famotidine had little or no effect on fasting or postprandial serum gastrin levels.

.

Cholestatic jaundice, hepatitis, liver enzyme abnormalities, vomiting, nausea, abdominal discomfort, anorexia, dry mouth. Bioavailability studies of 8 pediatric patients 11 to 15 years of age showed a mean oral bioavailability of 0. Trials have not assessed the safety of famotidine in uncomplicated active DU for periods of more than 8 weeks. Controlled trials have not extended beyond one year. North Wales, PA Rev. Report new cardiac symptoms, such as palpitations, fainting and dizziness or lightheadedness immediately to a healthcare provider. Hypersensitivity: orbital edema, rash, conjunctival injection, bronchospasm. These differences were statistically significant. Prolonged QT interval, in patients with impaired renal function, has been reported very rarely. The recommended oral dosage for the treatment of adult patients with esophagitis including erosions and ulcerations and accompanying symptoms due to GERD is 20 or 40 mg b. Compounds tested in man include warfarin, theophylline, phenytoin, diazepam, aminopyrine and antipyrine. Famotidine Famotidine 40 mg b. Famotidine has an elimination half-life of 2. Serum hormone levels, including prolactin, cortisol, thyroxine T 4 , and testosterone, were not altered after treatment with famotidine.